71 related articles for article (PubMed ID: 2640054)
1. [Effects of fructose-1,6-diphosphate in patients with chronic ischemic heart disease. Echocardiographic study].
Pasotti C; Nicrosini S; Fiori G
Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):315-20. PubMed ID: 2640054
[TBL] [Abstract][Full Text] [Related]
2. Improved left ventricular function after short-term treatment with fructose-1,6-diphosphate: echocardiographic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy.
Grandi AM; Muggia C; Barzizza F; Venco A; Finardi G
Clin Ther; 1988; 10(4):372-80. PubMed ID: 2978875
[TBL] [Abstract][Full Text] [Related]
3. [Improved cardiac performance with fructose-1,6-diphosphate in patients with ischemic heart disease].
Lureti FG; Poggi Longostrevi G
Riv Eur Sci Med Farmacol; 1988 Dec; 10(6):479-85. PubMed ID: 3274730
[No Abstract] [Full Text] [Related]
4. Recovery of post-arrest cardiac performance: effect of fructose-1,6-diphosphate in the isolated rabbit heart.
Merli M; Bergui G; Cattani C; Berti F; Marchetti M
Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):175-82. PubMed ID: 2799003
[TBL] [Abstract][Full Text] [Related]
5. [Fructose-1,6-diphosphate in the treatment of chronic heart failure].
Sun JP; Zhi G; Yang XS
Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):274-6, 314. PubMed ID: 2805965
[TBL] [Abstract][Full Text] [Related]
6. [Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].
Badalian GO; Episkoposian NG; Amatuni GV
Ter Arkh; 1987; 59(7):92-5. PubMed ID: 3672368
[TBL] [Abstract][Full Text] [Related]
7. Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat.
Didlake R; Kirchner KA; Lewin J; Bower JD; Markov A
Circ Shock; 1985; 16(2):205-12. PubMed ID: 4053295
[TBL] [Abstract][Full Text] [Related]
8. Improved exercise tolerance by i.v. fructose-1,6-diphosphate in chronic, stable angina pectoris.
Marchionni N; Moschi G; Di Bari M; Ferrucci L; Paoletti M; Salani B; Fattirolli F
J Clin Pharmacol; 1988 Sep; 28(9):807-11. PubMed ID: 3230148
[TBL] [Abstract][Full Text] [Related]
9. Effects of fructose-1,6-diphosphate on heart rate, ventilation, oxygen consumption and endurance performance.
Ripari P; Pieralisi G
Pharmatherapeutica; 1988; 5(4):249-55. PubMed ID: 3174724
[TBL] [Abstract][Full Text] [Related]
10. The use of fructose-1,6-diphosphate sodium salt (FDP) in burnt patients.
De Renzis A; Callegaris G; Vasi R
Agressologie; 1982 Dec; 23(7):321-3. PubMed ID: 6762826
[No Abstract] [Full Text] [Related]
11. A comparison between fructose 1,6-diphosphate, glucose, or normal saline infusions and species-specific blood exchange transfusions in the treatment of bowel ischemia.
Sawchuk A; Canal D; Slaughter M; Bearman D; O'Connor T; Grosfeld JL
Surgery; 1986 Oct; 100(4):665-70. PubMed ID: 3764691
[TBL] [Abstract][Full Text] [Related]
12. [Left ventricular behaviour before and after left anterior descending coronary artery bypass graft. M-mode echocardiographic study in 30 patients (author's transl)].
Castagnone M; Corallo S; Faletra F; Mantero A; Pezzano A
G Ital Cardiol; 1980; 10(4):405-13. PubMed ID: 6969197
[TBL] [Abstract][Full Text] [Related]
13. Irreversible hemorrhagic shock: treatment and cardiac pathophysiology.
Markov AK; Oglethorpe N; Young DB; Hellems HK
Circ Shock; 1981; 8(1):9-19. PubMed ID: 7237686
[TBL] [Abstract][Full Text] [Related]
14. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
[TBL] [Abstract][Full Text] [Related]
15. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure.
Lucas BD; Williams MA; Mohiuddin SM; LaMadrid LJ; Schroeder LJ; Hilleman DE
Pharmacotherapy; 1998; 18(4):824-30. PubMed ID: 9692655
[TBL] [Abstract][Full Text] [Related]
17. [Coronary circulation in asymmetrical hypertrophy of the interventricular septum. On a new pathogenic hypothesis].
Sánchez G; Orea A; Trevethan S; Martínez Ríos MA
Arch Inst Cardiol Mex; 1984; 54(3):235-44. PubMed ID: 6540552
[TBL] [Abstract][Full Text] [Related]
18. [Echocardiographic and polygraphic study of acute/effects of Ibopamine on cardiac performance].
Ladelli L; Pezzano A; Sala G; Mangiavacchi M; Cadel A; Brusoni B
G Ital Cardiol; 1983 Oct; 13(10):239-48. PubMed ID: 6667808
[TBL] [Abstract][Full Text] [Related]
19. [Fructose-1,6-diphosphate (FDP) in transitory myocardial ischemia induced by atrial pacing].
Malusardi R; Oddone A; Orlandi M; Manzi G
Minerva Cardioangiol; 1988 Sep; 36(9):439-44. PubMed ID: 3226574
[No Abstract] [Full Text] [Related]
20. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
Brown EJ; Erburu L; Kloner RA
J Med; 1987; 18(1):43-53. PubMed ID: 3474341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
